John Canepa
2021
In 2021, John Canepa earned a total compensation of $449.1K as Chief Financial Officer at Candel Therapeutics, a 66% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $74,000 |
---|---|
Salary | $370,000 |
Other | $5,123 |
Total | $449,123 |
Canepa received $370K in salary, accounting for 82% of the total pay in 2021.
Canepa also received $74K in non-equity incentive plan and $5.1K in other compensation.
Rankings
In 2021, John Canepa's compensation ranked 10,948th out of 12,406 executives tracked by ExecPay. In other words, Canepa earned more than 11.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 10,948 | 12th |
Manufacturing | 4,822 | 12th |
Chemicals And Allied Products | 2,158 | 9th |
Drugs | 1,919 | 8th |
Biological Products, Except Diagnostic Substances | 424 | 6th |
Canepa's colleagues
We found three more compensation records of executives who worked with John Canepa at Candel Therapeutics in 2021.